• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL3 通过 m6A 修饰增强 YTHDF1 对弥漫大 B 细胞淋巴瘤细胞中 NEDD1 mRNA 稳定性的影响。

METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.

机构信息

Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.

出版信息

Immun Inflamm Dis. 2023 Feb;11(2):e789. doi: 10.1002/iid3.789.

DOI:10.1002/iid3.789
PMID:36840486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9950878/
Abstract

AIM

Diffuse large B-cell lymphoma (DLBCL) remains the most frequent subpopulation of lymphoma, and N6-methyladenosine (m6A) was implicated in the DLBCL progression. Herein, we sought to decipher the m6A-asociated mechanism of NEDD1 in DLBCL development.

METHODS

The NEDD1 expression profile in DLBCL was assessed by quantitative real-time polymerase chain reaction (RT-qPCR) and Western blot. NEDD1 was artificially downregulated or upregulated in DLBCL cells, followed by EdU, Transwell assays and flow cytometry. The Hedgehog pathway activity was assayed by a dual-luciferase assay. The m6A methylation of NEDD1 in DLBCL was assessed by meRIP-qPCR, and the regulatory mechanism of METTL3 on NEDD1 was validated. The LDH assay was conducted to examine the impact of CD8 T cells on DLBCL cells. The DLBCL cells were administrated into mice to evaluate the tumorigenic activity and ki-67 activity in tumor tissues.

RESULTS

NEDD1 was overexpressed in DLBCL. Depletion of NEDD1 inhibited the aggressiveness of SU-DHL-8 and OCI-LY1 cells, whereas overexpression of NEDD1 expedited the aggressiveness of SU-DHL-8 and OCI-LY1 cells. METTL3 promoted NEDD1 translation in an m6A-dependent manner via YTHDF1. Depletion of METTL3 inhibited SU-DHL-8 and OCI-LY1 cell activity through regulation of NEDD1. NEDD1 reversed the repressive effect of METTL3 loss on the aggressiveness of SU-DHL-8 and OCI-LY1 cells. NEDD1 activated the Hedgehog signaling to promote immune escape of DLBCL.

CONCLUSIONS

METTL3 promotes translation of NEDD1 via YTHDF1-depedndent m6A modification, thereby activating the Hedgehog signaling pathway to promote immune escape of DLBCL cells.

摘要

目的

弥漫性大 B 细胞淋巴瘤(DLBCL)仍然是最常见的淋巴瘤亚群,N6-甲基腺苷(m6A)被认为与 DLBCL 的进展有关。在此,我们试图破译 NEDD1 在 DLBCL 发展中的 m6A 相关机制。

方法

通过定量实时聚合酶链反应(RT-qPCR)和 Western blot 评估 DLBCL 中的 NEDD1 表达谱。在 DLBCL 细胞中人工下调或上调 NEDD1,然后进行 EdU、Transwell 测定和流式细胞术。通过双荧光素酶测定法测定 Hedgehog 途径活性。通过 meRIP-qPCR 评估 DLBCL 中 NEDD1 的 m6A 甲基化,并验证 METTL3 对 NEDD1 的调节机制。LDH 测定法用于检查 CD8 T 细胞对 DLBCL 细胞的影响。将 DLBCL 细胞施用于小鼠以评估肿瘤组织中的肿瘤发生活性和 ki-67 活性。

结果

NEDD1 在 DLBCL 中过表达。NEDD1 的缺失抑制了 SU-DHL-8 和 OCI-LY1 细胞的侵袭性,而 NEDD1 的过表达则加速了 SU-DHL-8 和 OCI-LY1 细胞的侵袭性。METTL3 通过 YTHDF1 以 m6A 依赖性方式促进 NEDD1 的翻译。METTL3 的缺失通过调节 NEDD1 抑制了 SU-DHL-8 和 OCI-LY1 细胞的活性。NEDD1 逆转了 METTL3 缺失对 SU-DHL-8 和 OCI-LY1 细胞侵袭性的抑制作用。NEDD1 激活 Hedgehog 信号通路促进 DLBCL 细胞的免疫逃逸。

结论

METTL3 通过 YTHDF1 依赖性 m6A 修饰促进 NEDD1 的翻译,从而激活 Hedgehog 信号通路促进 DLBCL 细胞的免疫逃逸。

相似文献

1
METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.METTL3 通过 m6A 修饰增强 YTHDF1 对弥漫大 B 细胞淋巴瘤细胞中 NEDD1 mRNA 稳定性的影响。
Immun Inflamm Dis. 2023 Feb;11(2):e789. doi: 10.1002/iid3.789.
2
The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.m6A甲基转移酶METTL3通过调节PEDF中的m6A修饰在弥漫性大B细胞淋巴瘤(DLBCL)发展中发挥功能作用。
Front Genet. 2020 Aug 27;11:955. doi: 10.3389/fgene.2020.00955. eCollection 2020.
3
Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).甲基化识别蛋白 YTH N6-甲基腺苷 RNA 结合蛋白 1(YTHDF1)通过调节 CCR4-NOT 转录复合物亚基 7(CNOT7)的 m6A 水平调节骨肉瘤的增殖、迁移和侵袭。
Bioengineered. 2022 Mar;13(3):5236-5250. doi: 10.1080/21655979.2022.2037381.
4
FOXD2-AS1 is modulated by METTL3 with the assistance of YTHDF1 to affect proliferation and apoptosis in esophageal cancer.FOXD2-AS1在YTHDF1的协助下由METTL3调控,从而影响食管癌的增殖和凋亡。
Acta Pharm. 2025 Apr 10;75(1):69-86. doi: 10.2478/acph-2025-0009. Print 2025 Mar 1.
5
METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.METTL3通过以m6A依赖的方式调节miR-182成熟来促进前列腺癌进展。
Andrologia. 2022 Aug;54(7):1581-1591. doi: 10.1111/and.14422. Epub 2022 Apr 12.
6
LDHA- Mediated Histone Lactylation Promotes the Nonalcoholic Fatty Liver Disease Progression Through Targeting The METTL3/ YTHDF1/SCD1 m6A Axis.乳酸脱氢酶A介导的组蛋白乳酰化通过靶向METTL3/YTHDF1/SCD1 m6A轴促进非酒精性脂肪性肝病进展
Physiol Res. 2024 Dec 31;73(6):985-999. doi: 10.33549/physiolres.935289.
7
LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.长链非编码 RNA MALAT1 通过海绵吸附 miR-195 促进弥漫性大 B 细胞淋巴瘤的发生和免疫逃逸。
Life Sci. 2019 Aug 15;231:116335. doi: 10.1016/j.lfs.2019.03.040. Epub 2019 Mar 18.
8
METTL3 promotes the osteogenic differentiation of human periodontal ligament cells by increasing YAP activity via IGF2BP1 and YTHDF1-mediated mA modification.METTL3通过IGF2BP1和YTHDF1介导的m⁶A修饰增加YAP活性,从而促进人牙周膜细胞的成骨分化。
J Periodontal Res. 2024 Oct;59(5):1017-1030. doi: 10.1111/jre.13297. Epub 2024 Jun 4.
9
Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction-associated steatotic liver disease.Mettl3-m6A-YTHDF1 轴促进代谢相关脂肪性肝病中肝线粒体功能障碍。
Cell Signal. 2024 Sep;121:111303. doi: 10.1016/j.cellsig.2024.111303. Epub 2024 Jul 15.
10
The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.m6A 甲基转移酶 METTL3 介导的 DEK mRNA 的 N6-甲基腺苷化修饰促进胃癌细胞生长和转移。
Int J Mol Sci. 2022 Jun 9;23(12):6451. doi: 10.3390/ijms23126451.

引用本文的文献

1
m6A eraser ALKBH5/treRNA1/DDX46 axis regulates BCR expression.m6A去甲基化酶ALKBH5/treRNA1/DDX46轴调控BCR表达。
Neoplasia. 2025 Apr;62:101144. doi: 10.1016/j.neo.2025.101144. Epub 2025 Feb 22.
2
METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells.METTL3介导的C1qA的m6A甲基化调控弥漫性大B细胞淋巴瘤细胞的利妥昔单抗耐药性。
Cell Death Discov. 2023 Nov 1;9(1):405. doi: 10.1038/s41420-023-01698-2.

本文引用的文献

1
Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels.人工智能基于免疫肿瘤学和免疫检查点面板预测总生存期并对成熟B细胞肿瘤进行分类。
Cancers (Basel). 2022 Oct 28;14(21):5318. doi: 10.3390/cancers14215318.
2
METTL3 promotes cell cycle progression via mA/YTHDF1-dependent regulation of translation.METTL3 通过 mA/YTHDF1 依赖的翻译调控促进细胞周期进程。
Int J Biol Sci. 2022 May 1;18(8):3223-3236. doi: 10.7150/ijbs.70335. eCollection 2022.
3
Lactylation-driven METTL3-mediated RNA mA modification promotes immunosuppression of tumor-infiltrating myeloid cells.
乳糖化驱动的 METTL3 介导的 RNA mA 修饰促进肿瘤浸润髓系细胞的免疫抑制。
Mol Cell. 2022 May 5;82(9):1660-1677.e10. doi: 10.1016/j.molcel.2022.02.033. Epub 2022 Mar 22.
4
The mA RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia.毫微安RNA甲基转移酶METTL3/METTL14通过急性髓系白血病中的mdm2/p53途径促进白血病发生。
J Cancer. 2022 Jan 4;13(3):1019-1030. doi: 10.7150/jca.60381. eCollection 2022.
5
The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases.m6A阅读蛋白YTHDF1在肿瘤生物学和人类疾病中的作用及机制
Mol Ther Nucleic Acids. 2021 Nov 4;26:1270-1279. doi: 10.1016/j.omtn.2021.10.023. eCollection 2021 Dec 3.
6
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition.癌症相关的间充质干细胞驱动肿瘤免疫排斥和对免疫疗法的抗性,而这可以通过抑制刺猬信号通路来克服。
Sci Adv. 2021 Nov 12;7(46):eabi5790. doi: 10.1126/sciadv.abi5790.
7
Expression of N-methyladenosine (mA) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL).N6-甲基腺苷(m6A)调控因子的表达与免疫微环境特征相关,并可预测弥漫性大 B 细胞淋巴瘤(DLBCL)的预后。
Bioengineered. 2021 Dec;12(1):6115-6133. doi: 10.1080/21655979.2021.1972644.
8
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.N6-甲基腺苷相关长非编码 RNA 预后signature、免疫检查点和免疫细胞浸润的综合分析在透明细胞肾细胞癌中的研究。
Immun Inflamm Dis. 2021 Dec;9(4):1596-1612. doi: 10.1002/iid3.513. Epub 2021 Aug 25.
9
NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.NEDD9 过表达:急性髓系白血病的预后和指导价值。
J Cell Mol Med. 2021 Oct;25(19):9331-9339. doi: 10.1111/jcmm.16870. Epub 2021 Aug 25.
10
N-methyladenosine-modified circIGF2BP3 inhibits CD8 T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.N6-甲基腺苷修饰的环状 IGF2BP3 通过促进非小细胞肺癌中 PD-L1 的去泛素化来抑制 CD8 T 细胞反应,从而促进肿瘤免疫逃逸。
Mol Cancer. 2021 Aug 20;20(1):105. doi: 10.1186/s12943-021-01398-4.